Empagliflozin and Dulaglutide are Effective against Obesity-induced Airway Hyperresponsiveness and Fibrosis in A Murine Model
Open Access
- 30 October 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-8
Abstract
Patients with asthma with obesity experience severe symptoms, are unresponsive to conventional asthma treatment, and lack proper pharmacotherapy. Empagliflozin and dulaglutide, developed for diabetes, reduce weight, decrease insulin resistance, and exert additive effects. We evaluated the efficacy of empagliflozin, dulaglutide, and their combination on obesity-induced airway hyperresponsiveness (AHR) and lung fibrosis using a murine model. We assigned C57BL/6J mice to five groups: control, high-fat diet (HFD), and HFD with empagliflozin, dulaglutide, or both. Mice received a 12-week HFD, empagliflozin (5 days/week, oral gavage), and dulaglutide (once weekly, intraperitoneally). Both drugs significantly attenuated HFD-induced weight increase, abnormal glucose metabolism, and abnormal serum levels of leptin and insulin, and co-treatment was more effective. Both drugs significantly alleviated HFD-induced AHR, increased macrophages in bronchoalveolar lavage fluid (BALF), and co-treatment was more effective on AHR. HFD-induced lung fibrosis was decreased by both drugs alone and combined. HFD induced interleukin (IL)-17, transforming growth factor (TGF)-β1, and IL-1β mRNA and protein expression, which was significantly reduced by empagliflozin, dulaglutide, and their combination. Tumour necrosis factor (TNF)-α and IL-6 showed similar patterns without significant differences. HFD-enhanced T helper (Th) 1 and Th17 cell differentiation was improved by both drugs. Empagliflozin and dulaglutide could be a promising therapy for obesity-induced asthma and showed additive effects in combination.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2016R1A2B4014288)
This publication has 39 references indexed in Scilit:
- Effects of Diet-Induced Mild Obesity on Airway Hyperreactivity and Lung Inflammation in MiceYonsei Medical Journal, 2013
- Obesity in asthma: more neutrophilic inflammation as a possible explanation for a reduced treatment responseAllergy, 2012
- Asthma and obesity: A known association but unknown mechanismRespirology, 2012
- Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activationAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Adiponectin Deficiency Increases Allergic Airway Inflammation and Pulmonary Vascular RemodelingAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- Body mass index and asthma severity in the National Asthma SurveyThorax, 2008
- Obesity and asthma: lessons from animal modelsJournal of Applied Physiology, 2007
- Increased pulmonary responses to acute ozone exposure in obese db/db miceAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
- Influence of body mass index on the response to asthma controller agentsEuropean Respiratory Journal, 2006
- The epidemiology of obesity and asthmaJournal of Allergy and Clinical Immunology, 2005